PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 152 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,000 | 0.0% | 533 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | -33.3% | 533 | 0.0% | 0.00% | – |
| Q4 2019 | $3,000 | 0.0% | 533 | 0.0% | 0.00% | – |
| Q3 2019 | $3,000 | 0.0% | 533 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | +50.0% | 533 | +37.4% | 0.00% | – |
| Q1 2019 | $2,000 | 0.0% | 388 | 0.0% | 0.00% | – |
| Q4 2018 | $2,000 | 0.0% | 388 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | -33.3% | 388 | 0.0% | 0.00% | – |
| Q2 2018 | $3,000 | 0.0% | 388 | 0.0% | 0.00% | – |
| Q1 2018 | $3,000 | – | 388 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|